My Watchlist Items

      No Watchlist
Array ( [0] => stdClass Object ( [symbol] => HTBX [price] => 7.37 [beta] => 0.318257 [volAvg] => 990582 [mktCap] => 186116080 [lastDiv] => 0 [range] => 4.9-30.1 [changes] => -0.27 [companyName] => Heat Biologics, Inc. [currency] => USD [cik] => 0001476963 [isin] => US42237K3005 [cusip] => 42237K300 [exchange] => Nasdaq Capital Market [exchangeShortName] => NASDAQ [industry] => Biotechnology [website] => http://www.heatbio.com [description] => Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company is headquartered in Durham, North Carolina and currently employs 30 full-time employees. The firm is an immuno-oncology company, which focuses on T cell-stimulating platform technologies, such as Immune Pan-Antigen Cytotoxic Therapy (ImPACT) and Combination Pan-Antigen Cytotoxic Therapy (ComPACT). Using its ImPACT platform technology, the Company has developed HS-410 (vesigenurtacel-L) as a product candidate to treat non-muscle invasive bladder cancer (NMIBC), and HS-110 (viagenpumatucel-L), which is intended for use in combination with an anti-PD-1 checkpoint inhibitor, as a potential treatment for patients with non-small cell lung cancer (NSCLC). Using its ComPACT platform technology, it has developed HS-120 as a potential treatment for NSCLC. The company is conducting a Phase II trial of HS-410 in patients with NMIBC, and a Phase Ib trial of HS-110, in combination with nivolumab (Opdivo) to treat patients with NSCLC. [ceo] => Mr. Jeffrey Wolf [sector] => Healthcare [country] => US [fullTimeEmployees] => 39 [phone] => 19192407133 [address] => 627 DAVIS DRIVE, SUITE 400 [city] => Morrisville [state] => NORTH CAROLINA [zip] => 27560 [dcfDiff] => [dcf] => 9.55041 [image] => https://financialmodelingprep.com/image-stock/HTBX.png [ipoDate] => 2013-07-24 [defaultImage] => [isEtf] => [isActivelyTrading] => 1 ) )
Heat Biologics, Inc. (HTBX)
   7.37   -0.27(-3.53%)
Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company is headquartered in Durham, North Carolina and currently employs 30 full-time employees. The firm is an immuno-oncology company, which focuses on T cell-stimulating platform technologies, such as Immune Pan-Antigen Cytotoxic Therapy (ImPACT) and Combination Pan-Antigen Cytotoxic Therapy (ComPACT). Using its ImPACT platform technology, the Company has developed HS-410 (vesigenurtacel-L) as a product candidate to treat non-muscle invasive bladder cancer (NMIBC), and HS-110 (viagenpumatucel-L), which is intended for use in combination with an anti-PD-1 checkpoint inhibitor, as a potential treatment for patients with non-small cell lung cancer (NSCLC). Using its ComPACT platform technology, it has developed HS-120 as a potential treatment for NSCLC. The company is conducting a Phase II trial of HS-410 in patients with NMIBC, and a Phase Ib trial of HS-110, in combination with nivolumab (Opdivo) to treat patients with NSCLC.
TitleNamePayCurrency PayGenderYear BornTitle Since
Chief Medical Advisor Colonel George E. Peoples Jr., F.A.C.S., M.D., FACS N/A USD N/A N/A
Chief Medical Advisor and Member of Scientific & Clinical Advisory Board Dr. Justin Stebbing M.D., M.A., FRCP, FRCPath, Ph.D. N/A USD N/A N/A
Chief Financial Officer & Controller Mr. William L. Ostrander 230620 USD male 1968 N/A
Founder, Chairman, Chief Executive Officer & Pres Mr. Jeffrey Alan Wolf 808230 USD male 1963 N/A
SymbolDateRatingRating Score Rating Details
HTBX 11 June, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 10 June, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 9 June, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 8 June, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 7 June, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 4 June, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 3 June, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 2 June, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 1 June, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 28 May, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 27 May, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 26 May, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 25 May, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 24 May, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 21 May, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 20 May, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 19 May, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 18 May, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 17 May, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 14 May, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 13 May, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 12 May, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 11 May, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 10 May, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 7 May, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 6 May, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 5 May, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 4 May, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 3 May, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 30 April, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 29 April, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 28 April, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 27 April, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 26 April, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 23 April, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 22 April, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 21 April, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 20 April, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 19 April, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 16 April, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 15 April, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 14 April, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 13 April, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 12 April, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 9 April, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 8 April, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 7 April, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 6 April, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 5 April, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 1 April, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 31 March, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 30 March, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 29 March, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 26 March, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 25 March, 2021 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Buy)
HTBX 24 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 23 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 22 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 19 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 18 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 17 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 16 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 15 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 12 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 11 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 10 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 9 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 8 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 5 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 4 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 3 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 2 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 1 March, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 26 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 25 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 24 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 23 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 22 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 19 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 18 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 17 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 5 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 4 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 3 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 2 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 1 February, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 29 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 28 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 27 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 26 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 25 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 22 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 21 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 20 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 19 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 15 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 13 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 12 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 11 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HTBX 8 January, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Neutral)
Rating DCF: (Neutral)
Rating DE: (Neutral)
Rating PE: (Strong Sell)
Rating PB: (Strong Buy)
HolderSharesDate ReportedChange
HUNTINGTON NATIONAL BANK 1 31 March, 2021 0
BLACKROCK INC. 343724 31 December, 2020 -13
QUBE RESEARCH & TECHNOLOGIES LTD 183549 31 December, 2020 183549
PRINCIPAL FINANCIAL GROUP INC 140668 31 December, 2020 140668
GEODE CAPITAL MANAGEMENT, LLC 134762 31 December, 2020 1008
CAPSTONE INVESTMENT ADVISORS, LLC 57413 31 December, 2020 57413
HRT FINANCIAL LP 50151 31 December, 2020 50151
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 45504 31 December, 2020 19543
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 41313 31 December, 2020 -859
NORTHERN TRUST CORP 39772 31 December, 2020 203
MILLENNIUM MANAGEMENT LLC 36932 31 December, 2020 36932
MORGAN STANLEY 35059 31 December, 2020 10781
WELLS FARGO & COMPANY/MN 29001 31 December, 2020 28871
PRICE T ROWE ASSOCIATES INC /MD/ 21270 31 December, 2020 16270
LOS ANGELES CAPITAL MANAGEMENT LLC 18370 31 December, 2020 18370
HIGHTOWER ADVISORS, LLC 16782 31 December, 2020 -2770
STATE STREET CORP 16256 31 December, 2020 -1
BANK OF NEW YORK MELLON CORP 16115 31 December, 2020 10377
VANGUARD GROUP INC 1044784 31 December, 2020 179056
EDMOND DE ROTHSCHILD HOLDING S.A. 14285 31 December, 2020 -1
MIRABELLA FINANCIAL SERVICES LLP 13055 31 December, 2020 -5231
SUGARLOAF WEALTH MANAGEMENT, LLC 2897 31 December, 2020 4
COMMUNITY BANK, N.A. 1928 31 December, 2020 -1
TRU INDEPENDENCE LLC 1285 31 December, 2020 1285
VALLEY NATIONAL ADVISERS INC 714 31 December, 2020 0
BANK OF AMERICA CORP /DE/ 432 31 December, 2020 0
BANK OF MONTREAL /CAN/ 314 31 December, 2020 0
ADVISOR GROUP HOLDINGS, INC. 215 31 December, 2020 -158
ADVISORY SERVICES NETWORK, LLC 214 31 December, 2020 0
PRIME CAPITAL INVESTMENT ADVISORS, LLC 214 31 December, 2020 0
BARON SILVER STEVENS FINANCIAL ADVISORS, LLC 185 31 December, 2020 185
JPMORGAN CHASE & CO 108 31 December, 2020 -3878
NORTH STAR INVESTMENT MANAGEMENT CORP. 102 31 December, 2020 0
DEUTSCHE BANK AG\ 1 31 December, 2020 1
UBS GROUP AG 14831 31 December, 2020 6901
ETRADE CAPITAL MANAGEMENT LLC 3661 30 September, 2020 3661
HolderSharesDate ReportedWeight Percent
Vanguard Total Stock Market Index Fund 2366990 31 August, 2020 N/A
Vanguard Extended Market Index Fund 1073570 31 July, 2020 N/A
Fidelity Extended Market Index Fund 249803 31 July, 2020 N/A
Vanguard Institutional Total Stock Market Index Fund 81097 31 July, 2020 N/A
Fidelity Series Total Market Index Fund 57503 31 July, 2020 N/A
Vanguard US Equity Index Fund 44593 31 July, 2020 N/A
Fidelity NASDAQ Composite Index Fund 33671 31 July, 2020 N/A
Vanguard Balanced Index Fund 28258 31 July, 2020 N/A
Fidelity Total Market Index Fund 19197 31 July, 2020 N/A
Master Extended Market Index Series-Quantitative Master Series LLC 13524 30 June, 2020 N/A
SymbolTransaction DateReporting CikSecurities Owned Company CikReporting NameAcquistion Or DispositionForm Type Securities TransactedSecurity NameLink
HTBX 4 January, 2021 0001257825 65217 0001476963 MONAHAN JOHN J A 4 65217 Stock Options View
HTBX 4 January, 2021 0001381450 147980 0001476963 Wolf Jeffrey Alan A 4 147980 Stock options View
HTBX 4 January, 2021 0001788229 51487 0001476963 Ostrander William L. D 4 51487 Stock Options View
HTBX 4 January, 2021 0001381450 766484 0001476963 Wolf Jeffrey Alan A 4 288100 Common Stock View
HTBX 4 January, 2021 0001042019 238272 0001476963 PRENDERGAST JOHN K A A 4 138272 Common Stock View
HTBX 4 January, 2021 0001436316 65217 0001476963 Smith Edward B III A 4 65217 Stock Options View
HTBX 12 November, 2020 0001436316 0 0001476963 Smith Edward B III D 4 103304 Common Stock View
HTBX 24 August, 2020 0001381450 1412100 0001476963 Wolf Jeffrey Alan A 4 1412100 Stock options View
HTBX 13 August, 2020 0001788229 15625 0001476963 Ostrander William L. A 4 15625 Common Stock View
HTBX 13 August, 2020 0001788229 59375 0001476963 Ostrander William L. D 4 15625 Employee Stock Option (right to buy) View
HTBX 13 August, 2020 0001788229 11185 0001476963 Ostrander William L. D 4 4440 Common Stock View
HTBX 28 July, 2020 0001381450 2000000 0001476963 Wolf Jeffrey Alan A 4 2000000 Stock options View
HTBX 12 March, 2020 0001694022 500000 0001476963 Hutchins Jeff Tobin A 4 500000 Stock Options View
HTBX 12 March, 2020 0001788229 150000 0001476963 Ostrander William L. A 4 150000 Stock Options View
HTBX 2 January, 2020 0001381450 3768693 0001476963 Wolf Jeffrey Alan A 4 1980000 Common Stock View
HTBX 2 January, 2020 0001042019 700000 0001476963 PRENDERGAST JOHN K A A 4 400000 Common Stock View
HTBX 2 January, 2020 0001257825 150000 0001476963 MONAHAN JOHN J A 4 150000 Stock Options View
HTBX 2 January, 2020 0001436316 150000 0001476963 Smith Edward B III A 4 150000 Stock Options View
HTBX 31 December, 2019 0001381450 1788693 0001476963 Wolf Jeffrey Alan A 4 900000 Common Stock View
HTBX 30 December, 2019 0001381450 1788693 0001476963 Wolf Jeffrey Alan A 4/A 900000 Common Stock View
HTBX 25 September, 2019 0001788229 75000 0001476963 Ostrander William L. A 4 75000 Stock Options View
HTBX 1 April, 2019 0001293575 75000 0001476963 Jakobs Robert James A 4 75000 Stock Options View
HTBX 1 January, 2019 0001042019 300000 0001476963 PRENDERGAST JOHN K A A 4 300000 Common Stock View
HTBX 1 January, 2019 0001381450 848317 0001476963 Wolf Jeffrey Alan A 4 800000 Common Stock View
HTBX 1 January, 2019 0001461733 110570 0001476963 Rosar Ann A A 4 110570 Stock Options View
HTBX 1 January, 2019 0001461733 93379 0001476963 Rosar Ann A A 4 89430 Common Stock View
HTBX 1 January, 2019 0001694022 356860 0001476963 Hutchins Jeff Tobin A 4 356860 Stock Options View
HTBX 1 January, 2019 0001694022 143140 0001476963 Hutchins Jeff Tobin A 4 143140 Common Stock View
HTBX 1 January, 2019 0001381450 888693 0001476963 Wolf Jeffrey Alan A 4/A 800000 Common Stock View
HTBX 1 January, 2019 0001381450 800000 0001476963 Wolf Jeffrey Alan A 4 800000 Stock Options View
HTBX 1 January, 2019 0001257825 150000 0001476963 MONAHAN JOHN J A 4 150000 Stock Options View
HTBX 1 January, 2019 0001436316 150000 0001476963 Smith Edward B III A 4 150000 Stock Options View
HTBX 8 January, 2018 0001381450 595588 0001476963 Wolf Jeffrey Alan A 4 595588 Stock Options View
HTBX 8 January, 2018 0001461733 66176 0001476963 Rosar Ann A A 4 66176 Stock Options View
HTBX 8 January, 2018 0001461733 108236 0001476963 Rosar Ann A A 4 45000 Common Stock View
HTBX 8 January, 2018 0001694022 296471 0001476963 Hutchins Jeff Tobin A 4 296471 Stock Options View
HTBX 8 January, 2018 0001381450 886950 0001476963 Wolf Jeffrey Alan A 4 665720 Common Stock View
HTBX 8 January, 2018 0001042019 190588 0001476963 PRENDERGAST JOHN K A A 4 190588 Stock Option View
HTBX 8 January, 2018 0001257825 95294 0001476963 MONAHAN JOHN J A 4 95294 Stock Option View
HTBX 8 January, 2018 0001436316 95294 0001476963 Smith Edward B III A 4 95294 Stock Options View
HTBX 29 June, 2017 0001461733 25000 0001476963 Rosar Ann A A 4 25000 Stock Options View
HTBX 29 June, 2017 0001694022 100000 0001476963 Hutchins Jeff Tobin A 4 100000 Stock Options View
HTBX 28 April, 2017 0001381450 716195 0001476963 Wolf Jeffrey Alan A 4 179333 Common Stock View
HTBX 28 April, 2017 0001381450 771723 0001476963 Wolf Jeffrey Alan A 4 76070 Common Stock View
HTBX 28 April, 2017 0001381450 221230 0001476963 Wolf Jeffrey Alan A 4 16349 Common Stock View
HTBX 28 April, 2017 0001257825 5169 0001476963 MONAHAN JOHN J A 4 3958 Common Stock View
HTBX 28 April, 2017 0001436316 1033046 0001476963 Smith Edward B III A 4 335743 Common Stock View
HTBX 28 April, 2017 0001436316 10010 0001476963 Smith Edward B III A 4 10010 Common Stock View
HTBX 7 February, 2017 0001461733 63236 0001476963 Rosar Ann A D 4 6764 Common Stock View
HTBX 2 January, 2017 0001381450 204881 0001476963 Wolf Jeffrey Alan A 4 125000 Common Stock View
HTBX 2 January, 2017 0001381450 125000 0001476963 Wolf Jeffrey Alan A 4 125000 Stock Options View
HTBX 2 January, 2017 0001461733 70000 0001476963 Rosar Ann A A 4 70000 Common Stock View
HTBX 2 January, 2017 0001694022 200000 0001476963 Hutchins Jeff Tobin A 4 200000 Stock Options View
HTBX 2 January, 2017 0001042019 180000 0001476963 PRENDERGAST JOHN K A A 4 180000 Stock Option View
HTBX 2 January, 2017 0001257825 90000 0001476963 MONAHAN JOHN J A 4 90000 Stock Option View
HTBX 2 January, 2017 0001436316 90000 0001476963 Smith Edward B III A 4 90000 Stock Options View
HTBX 30 December, 2016 0001381450 79881 0001476963 Wolf Jeffrey Alan A 4 75000 Common Stock View
HTBX 30 December, 2016 0001381450 75000 0001476963 Wolf Jeffrey Alan A 4 75000 Stock Options View
HTBX 21 April, 2016 0001042019 40000 0001476963 PRENDERGAST JOHN K A A 4 40000 Stock Option View
HTBX 5 April, 2016 0001461733 20000 0001476963 Rosar Ann A A 4 20000 Stock Option View
HTBX 23 March, 2016 0001075080 675000 0001476963 KHARITONOV MICHAEL A 4 675000 Warrants View
HTBX 23 March, 2016 0001075080 949960 0001476963 KHARITONOV MICHAEL A 4 900000 Common Stock View
HTBX 11 January, 2016 0001587775 51587 0001476963 Price Melissa A 4 51587 Stock Options View
HTBX 11 January, 2016 0001257825 23810 0001476963 MONAHAN JOHN J A 4 23810 Stock Options View
HTBX 11 January, 2016 0001580270 23810 0001476963 Belsky Paul A 4 23810 Stock Options View
HTBX 11 January, 2016 0001594811 21587 0001476963 Goyal Anil K. A 4 21587 Stock Options View
HTBX 11 January, 2016 0001601942 57567 0001476963 Schreiber Taylor A 4 57567 Stock Options View
HTBX 11 January, 2016 0001381450 94048 0001476963 Wolf Jeffrey Alan A 4 94048 Stock Options View
HTBX 11 January, 2016 0001075080 23810 0001476963 KHARITONOV MICHAEL A 4 23810 Stock Options View
HTBX 11 January, 2016 0001279735 23810 0001476963 BOCK LOUIS C A 4 23810 Stock Options View
HTBX 11 January, 2016 0001436316 23810 0001476963 Smith Edward B III A 4 23810 Stock Options View
HTBX 30 November, 2015 0001183898 70000 0001476963 CREECH TIMOTHY J A 4 70000 Stock Options View
HTBX 23 July, 2015 0001601942 35000 0001476963 Schreiber Taylor A 4 35000 Stock Options View
HTBX 12 January, 2015 0001601942 10000 0001476963 Schreiber Taylor A 4 10000 Stock Options View
HTBX 12 January, 2015 0001594811 12500 0001476963 Goyal Anil K. A 4 12500 Stock Options View
HTBX 12 January, 2015 0001381450 12500 0001476963 Wolf Jeffrey Alan A 4 12500 Stock Options View
HTBX 15 October, 2014 0001587775 10000 0001476963 Price Melissa A 4 10000 Stock Options View
HTBX 11 June, 2014 0001279735 6483 0001476963 BOCK LOUIS C A 4 6483 Stock Options View
HTBX 11 June, 2014 0001601942 50000 0001476963 Schreiber Taylor A 4 50000 Stock Option View
HTBX 11 June, 2014 0001075080 6483 0001476963 KHARITONOV MICHAEL A 4 6483 Stock Options View
HTBX 11 June, 2014 0001257825 6483 0001476963 MONAHAN JOHN J A 4 6483 Common Stock View
HTBX 11 June, 2014 0001436316 0 0001476963 Smith Edward B III A 4 6483 Stock Options View
HTBX 11 June, 2014 0001580270 6483 0001476963 Belsky Paul A 4 6483 Stock Options View
HTBX 5 June, 2014 0001587775 346 0001476963 Price Melissa A 4 346 Common Stock View
HTBX 5 June, 2014 0001587775 692 0001476963 Price Melissa A 4 346 Common Stock View
HTBX 19 May, 2014 0001381450 3660 0001476963 Wolf Jeffrey Alan A 4 346 Common Stock View
HTBX 19 May, 2014 0001381450 3314 0001476963 Wolf Jeffrey Alan A 4 400 Common Stock View
HTBX 19 May, 2014 0001381450 2914 0001476963 Wolf Jeffrey Alan A 4 1754 Common Stock View
HTBX 16 May, 2014 0001580270 47190 0001476963 Belsky Paul A 4 1265 Common Stock View
HTBX 16 May, 2014 0001580270 45925 0001476963 Belsky Paul A 4 1235 Common Stock View
HTBX 17 January, 2014 0001208291 48364 0001476963 CZAJKOWSKI MATTHEW E A 4 10000 Stock Option View
HTBX 17 January, 2014 0001381450 219661 0001476963 Wolf Jeffrey Alan A 4 100000 Stock Options View
HTBX 29 July, 2013 0001381450 0 0001476963 Wolf Jeffrey Alan D 4 1160 Series B-1 Preferred View
HTBX 29 July, 2013 0001381450 1233726 0001476963 Wolf Jeffrey Alan A 4 51 Common Stock View
HTBX 29 July, 2013 0001381450 1233675 0001476963 Wolf Jeffrey Alan A 4 1160 Common Stock View
HTBX 29 July, 2013 0001075080 0 0001476963 KHARITONOV MICHAEL D 4 49960 Series 1 Preferred View
HTBX 29 July, 2013 0001075080 49960 0001476963 KHARITONOV MICHAEL A 4 49960 Common Stock View
HTBX 29 July, 2013 0001257825 0 0001476963 MONAHAN JOHN J D 4 1160 Series B-1 Preferred View
HTBX 29 July, 2013 0001257825 1211 0001476963 MONAHAN JOHN J A 4 51 Common Stock View
HTBX 29 July, 2013 0001257825 1160 0001476963 MONAHAN JOHN J A 4 1160 Common Stock View
SymbolDatePeriodDownload XLSX File
HTBX 2021 FY Download XLSX File
HTBX 2020 FY Download XLSX File
HTBX 2019 FY Download XLSX File
HTBX 2018 FY Download XLSX File
HTBX 2017 FY Download XLSX File
HTBX 2016 FY Download XLSX File
HTBX 2015 FY Download XLSX File
HTBX 2014 FY Download XLSX File
HTBX 2013 FY Download XLSX File
HTBX 2021 Q1 Download XLSX File
HTBX 2020 Q1 Download XLSX File
HTBX 2020 Q4 Download XLSX File
HTBX 2020 Q3 Download XLSX File
HTBX 2020 Q2 Download XLSX File
HTBX 2019 Q2 Download XLSX File
HTBX 2019 Q4 Download XLSX File
HTBX 2019 Q3 Download XLSX File
HTBX 2019 Q1 Download XLSX File
HTBX 2018 Q2 Download XLSX File
HTBX 2018 Q4 Download XLSX File
HTBX 2018 Q3 Download XLSX File
HTBX 2018 Q1 Download XLSX File
HTBX 2017 Q2 Download XLSX File
HTBX 2017 Q1 Download XLSX File
HTBX 2017 Q3 Download XLSX File
HTBX 2017 Q4 Download XLSX File
HTBX 2016 Q1 Download XLSX File
HTBX 2016 Q4 Download XLSX File
HTBX 2016 Q3 Download XLSX File
HTBX 2016 Q2 Download XLSX File
HTBX 2015 Q3 Download XLSX File
HTBX 2015 Q4 Download XLSX File
HTBX 2015 Q2 Download XLSX File
HTBX 2015 Q1 Download XLSX File
HTBX 2014 Q2 Download XLSX File
HTBX 2014 Q4 Download XLSX File
HTBX 2014 Q1 Download XLSX File
HTBX 2014 Q3 Download XLSX File
HTBX 2013 Q2 Download XLSX File
HTBX 2013 Q3 Download XLSX File
HTBX 2013 Q4 Download XLSX File

Charts

Company Historical Earnings

DateSymbolEPSEPS EstimatedTimeRevenueRevenue Estimated
5 May, 2021 HTBX bmo 0 0
25 March, 2021 HTBX -0.02 -0.02 bmo 603192 0
7 August, 2020 HTBX -0.05 -0.05 bmo 593170 1067706
15 May, 2020 HTBX -0.11 -0.11 bmo 901880 819890.90909091
30 March, 2020 HTBX -0.1 -0.1 bmo 1999120 2798768
14 November, 2019 HTBX -0.18 -0.18 bmo 6440 5008.8888888889
14 August, 2019 HTBX -0.14 -0.14 bmo 342490 269099.28571429
15 May, 2019 HTBX -0.11 -0.11 bmo 701060 1210921.8181818
28 March, 2019 HTBX -0.15 -0.15 bmo 2058140 2606977.3333333
14 November, 2018 HTBX -0.16 -0.16 bmo 1840010 2415013.125
14 August, 2018 HTBX -0.27 -0.27 bmo 1140000 760000
15 May, 2018 HTBX bmo 750000 0
2 March, 2018 HTBX -0.38 -0.38 bmo 610000 1123684.2105263
13 November, 2017 HTBX -0.6 -0.6 bmo 470000 705000
14 August, 2017 HTBX -0.9 -0.9 bmo 410000 455555.55555556
11 May, 2017 HTBX -1.2 -1.2 bmo 20000 25000
31 March, 2017 HTBX -1.2 -1.2 bmo 120000 70000
10 November, 2016 HTBX -0.8 -0.8 bmo 220000 412500
15 August, 2016 HTBX -1.7 -1.7 bmo 0 0
11 May, 2016 HTBX -5 -5 bmo 0 0
18 February, 2016 HTBX -7.8 -7.8 bmo 0 0
30 October, 2015 HTBX -0.62 -0.62 bmo 0 0
13 August, 2015 HTBX -0.56 -0.56 bmo 0 0
14 May, 2015 HTBX -0.57 -0.57 bmo 0 0
27 March, 2015 HTBX -0.56 -0.56 bmo 0 0
14 November, 2014 HTBX -0.46 -0.46 bmo 0 0
14 August, 2014 HTBX -0.44 -0.44 bmo 0 0
12 May, 2014 HTBX -3.6 -3.6 bmo 0 0
1 April, 2014 HTBX -5.5 -5.5 bmo 0 0
14 November, 2013 HTBX -4.8 -4.8 bmo 0 0

Company Profile

Company Name Heat Biologics, Inc.
Symbol HTBX
Currency USD
Price 7.37
Exchange Name Nasdaq Capital Market (NASDAQ)
Industry Biotechnology
CEO Mr. Jeffrey Wolf
Sector Healthcare
Country US
Full Time Employees 39
Phone 19192407133
Address 627 DAVIS DRIVE, SUITE 400
City Morrisville
State NORTH CAROLINA
Zip 27560
>